Therapeutic efficacy and safety profile of infliximab in active systemic lupus erythematosus

Author： Hayat Sawsan Johar   Uppal Sukhbir Singh  

Publisher： Springer Publishing Company

ISSN： 1439-7595

Source： Modern Rheumatology, Vol.17, Iss.2, 2007-04, pp. : 174-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis

By Hayat Sawsan   Uppal Sukhbir   Narayanan Nampoory M.   Johny Kaivilayil   Gupta Ramkumar   Al-Oun Mohammed  

Clinical Rheumatology, Vol. 26, Iss. 6, 2007-06 ,pp. : 973-975

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic Perspectives in Systemic Lupus Erythematosus

By  

Current Rheumatology Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 45-47

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic lupus erythematosus: a therapeutic challenge for the XXI century

By Ugarte-Gil Manuel   Alarcón Graciela  

Clinical Rheumatology, Vol. 33, Iss. 4, 2014-04 ,pp. : 441-450

Springer Publishing Company

Access to resources Recommend Favorite

Safety of Hormonal Replacement Therapy in Postmenopausal Patients with Systemic Lupus Erythematosus

By Mok C.C   Lau C.S   Ho C.T.K   Lee K.W   Mok M.Y   Wong R.W.S  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 5, 1998-10 ,pp. : 342-346

Informa Healthcare

Access to resources Recommend Favorite

Malignancies in systemic lupus erythematosus

By Kale Mruganka   Ramsey-Goldman Rosalind   Gordon Caroline   Clarke Ann E   Bernatsky Sasha  

International Journal of Clinical Rheumatology, Vol. 8, Iss. 2, 2013-04 ,pp. : 275-280

Future Medicine

Access to resources Recommend Favorite